ESTRO 2023 - Abstract Book

Symposium Individualising radiotherapy dose according to normal tissue effects - Are we there yet?.................... (abs. 0521-0523) Do radiotherapy techniques impact the concept and size of planning target volumes margins?......... (abs. 0524-0526) Joint Symposium ESTRO-IASLC: New treatment strategies for stage III NSCLC and innovative biomarkers for patient’s selection and monitoring. ..................................................................................................................................................... (abs. 0527-0530) Debate This house believes that C-arm linac is no longer the work-horse of radiotherapy................................ (abs. 0531-0536) Symposium AI for (online?) IGRT........................................................................................................................................ (abs. 0537-0541) Supportive care and toxicity assessment in brachytherapy. ..................................................................... (abs. 0542-0545) The role of radiation therapists in translating science to clinical practice. .............................................. (abs. 0546-0548) Mini-Oral CNS................................................................................................................................................................... (abs. 0549-0556) Patient and public perspective...................................................................................................................... (abs. 0557-0564) Poster Discussion Urology............................................................................................................................................................ (abs. 0565-0576) QA and auditing.............................................................................................................................................. (abs. 0577-0588) Proffered Papers Patient perspectives....................................................................................................................................... (abs. 0589-0594) Normal tissue radiobiology........................................................................................................................... (abs. 0595-0600) Gynaecology.................................................................................................................................................... (abs. 0601-0606) Lung................................................................................................................................................................. (abs. 0607-0612) Dose accumulation and dose prediction. .................................................................................................... (abs. 0613-0618) Photon treatment planning........................................................................................................................... (abs. 0619-0624) Urology............................................................................................................................................................ (abs. 0625-0630) Head and neck & physics............................................................................................................................... (abs. 0631-0636) Mini-Oral Radiotherapy and the heart.......................................................................................................................... (abs. 0637-0644) Poster Discussion CNS................................................................................................................................................................... (abs. 0645-0656) Imaging............................................................................................................................................................ (abs. 0657-0668) Mini-Oral Detectors & dose management.................................................................................................................... (abs. 0669-0676)